Israel Cancer Research Fund (ICRF) - Toronto

06/08/2026

It's time to recognize the breakthroughs reshaping how we treat cancer by harnessing the body’s own immune system 🧬

We’re proud to highlight new ICRF-supported research from The Hebrew University of Jerusalem Professors Gilad Bachrach and Ofer Mandelboim. Their recent study, published in Cells, explored how an inactivated strain of E. coli bacteria can stimulate a strong immune response against bladder tumors, while showing lower toxicity compared to standard treatment approaches.

This work reflects the growing promise of immunotherapy: more targeted, less invasive, and increasingly effective strategies that are changing outcomes for patients.

06/05/2026

Thank you to everyone who joined us on June 2nd for ICRF’s Health Series event, A New Frontier for Treating Brain Cancer 🧠

It was an inspiring evening bringing together leaders in science, medicine, and community impact to explore the future of brain cancer research and treatment.

We were honoured to hear from Dr. Tali Ilovitsh, who travelled from Israel to share her groundbreaking work, and Dr. James Perry, neuro-oncologist at Sunnybrook Health Sciences Centre and the University of Toronto, for their thoughtful and insightful discussion.

A sincere thank you to our speakers: Dr. Tali Ilovitsh, Dr. James Perry, Dr. Jay Detsky, Dr. Stuart Selby, Dr Neil Berinstein. Events like these remind us of the power of collaboration in advancing life-changing research.

06/03/2026

05/30/2026

We’re proud to share a new article from JTA News highlighting ICRF-supported scientists advancing critical colorectal cancer research 🗞️

As this disease rises among younger populations and remains two to three times more prevalent in Ashkenazi Jews, their work in early detection, treatment, and understanding genetic risk is more urgent than ever.

Researchers like Nir London, a drug discovery expert working to target the specific mutations that drive cancer growth, are helping push this work forward, bringing us closer to more effective, less toxic treatments.

Read the full article at the link: https://linktr.ee/icrftor

05/29/2026

What if radiation treatment could adapt in real time to each patient?
​
Dr. Jay Detsky, Radiation Oncologist and leader of the UNITED trial, is helping make that a reality through adaptive MR-guided radiation, propelling a major advancement in precision cancer care forward. Join us for a new Health Series to learn more:

🗓️ June 2, 2026
🕚 7:30–9:30 p.m.
📍 Temple Sinai, Toronto

Tickets available here: https://icrftoronto.givecloud.co/braincancer-healthseries

05/28/2026

Last chance to secure your spot at Health Series: A New Frontier for Treating Brain Cancer on June 2nd, 7:30–9:30 p.m. 🧠🎟️

Each year, thousands of Canadians are diagnosed with brain tumors. At ICRF, research is our hope.

We’re proud to welcome an incredible panel of speakers, including Dr. Tali Ilovitsh, Dr. James Perry, Dr. Neil Berinstein, Stuart Selby, and Dr. Jay Detsky—leaders in science, medicine, and brain cancer research.

🗓️ June 2, 2026�
🕚 7:30–9:30 p.m.�
📍Temple Sinai, 210 Wilson Ave, Toronto

Tickets are still available—but only for a short time. Secure yours now at the link: https://icrftoronto.givecloud.co/braincancer-healthseries

05/27/2026

Researchers at the Technion - Israel Institute of Technology have developed a groundbreaking AI model that can predict whether breast cancer patients will benefit from chemotherapy using routine pathology samples instead of costly, time-consuming genomic tests 🧬

For the thousands of Canadians diagnosed with breast cancer each year, this kind of innovation means faster decisions, fewer unnecessary treatments, and better outcomes. At ICRF, this is exactly the future we're funding.

05/25/2026

Skin cancer is one of the most common cancers worldwide, and cases are rising. At ICRF, researchers like Prof. Emily Avitan-Hersh are working to change that 👇

Prof. Avitan-Hersh is the Director of Dermatology and Head of the Melanoma Surveillance Program at Rambam Health Care Campus - Hospital in Israel. Through the Daisy Ge**er Memorial Project Grant, she is investigating a key receptor called CXCR7 and how it affects tumor growth and the immune system's ability to fight skin cancer. Her goal: to improve the effectiveness of immunotherapy for patients with advanced squamous cell carcinoma, one of the most aggressive forms of skin cancer.

This is what the answer to cancer looks like.

05/23/2026

Meet Stuart Selby, BSc (Biochemistry), former Pharmaceutical R&D professional and now Engagement Ambassador with Brain Cancer Canada.

After more than two decades in research and development, Stuart brings a uniquely personal and powerful perspective to brain cancer discourse.

Be part of the conversation at our Health Series event:
🗓️ June 2, 2026
🕚 7:30–9:30 p.m.
📍 Temple Sinai, Toronto

Tickets available here: https://icrftoronto.givecloud.co/braincancer-healthseries

05/21/2026

As we gather with family and friends to celebrate Shavuot, we reflect on the values of wisdom, perseverance, and renewal.

At ICRF, these same values inspire the Israeli scientists and researchers working tirelessly to unlock breakthroughs in cancer research and improve lives around the world.

This holiday, we celebrate the power of knowledge—not only to inspire, but to heal. Wishing our community a joyful and meaningful Shavuot.

Chag Sameach!